You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

Article info

Article menu

Download PDFPDF

XML
Research Article
Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

Authors

  • Jaina M. Patel Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research CenterEarle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA PubMed articlesGoogle scholar articles
  • Zhihua Cui Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research CenterEarle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA PubMed articlesGoogle scholar articles
  • Zhi-Fa Wen Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research CenterEarle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA Department of Microbiology and ImmunologyMedical School of Southeast University Nanjing Jiangsu Province People’s Republic of China PubMed articlesGoogle scholar articles
  • Catherine T. Dinh Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research CenterEarle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA PubMed articlesGoogle scholar articles
  • Hong-Ming Hu Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research CenterEarle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA PubMed articlesGoogle scholar articles
  1. ↵e 503-215-3896 hhu{at}providence.org
View Full Text

Citation

Patel JM, Cui Z, Wen Z, et al
Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism
Journal for ImmunoTherapy of Cancer 2019;7:311. doi: 10.1186/s40425-019-0786-7

Publication history

  • Received July 16, 2019
  • Accepted October 22, 2019
  • First published November 20, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.